ClinicalTrials HQ

Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC

Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLC

Active, not recruiting · NCT05798663 · Registry updated 2026-10-01
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Atezolizumab Immunotherapy With or Without Tiragolumab for Patients With Unresectable Stage III NSCLCnon-small cell lung carcinomaActive, not recruitingPhase 22026-10-01NCT05798663

2 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
Alliance Foundation Trials, LLC.12
Genentech, Inc.221

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Hematology Oncology Associates of Central New York, P.C.East SyracuseUnited States1
Kaiser Permanente Oakland Medical CenterOaklandUnited States8
Kaiser Permanente Roseville Medical CenterRosevilleUnited States7
Kaiser Permanente San Francisco Medical CenterSan FranciscoUnited States6
Kaiser Permanente Santa Clara Medical CenterSanta ClaraUnited States6
Kaiser Permanente Vallejo Medical CenterVallejoUnited States4
Missouri Baptist Medical CenterSt LouisUnited States252
New Hampshire Oncology - Hematology, PAManchesterUnited States1
Ohio State UniversityColumbusUnited States169
Rush University Medical CenterChicagoUnited States283
SUNY Upstate Medical UniversitySyracuseUnited States68
University of California San Diego Moores Cancer CenterLa JollaUnited States4
University of Nebraska Medical CenterOmahaUnited States397
University of WisconsinMadisonUnited States85
Washington University Siteman Cancer CenterSt LouisUnited States3